-The Times of India WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight. Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the ''poster child for price gouging in...
More »SEARCH RESULT
The post-dengue prognosis -K Srinath Reddy & NR Narayana Murthy
-The Indian Express The steady state efficiency of healthcare needs to be raised so that crises like this one can be avoided. In any free society where terrible wrongs exist, some are guilty; all are responsible.” While these words of Rabbi Abraham Joshua Heschel ring true for many social and political ills that appall us, they are also a timely reminder of our collective responsibility to correct the pathetic state of...
More »Lie of the land: Only 39 of 133 GM crop field trials monitored in 6 years -Dipu Rai
-DNA The Centre has always claimed that the country has a robust regulatory mechanism Busting the claims of the Indian government and scientists that the country has a robust regulatory mechanism to test genetically modified (GM) crops, toxic loopholes are emerging. From 2008 to 2014, only 39 of the 133 GM crop field trials were properly monitored, leaving the rest for unknown risks and possible health hazards to common people. Documents accessed...
More »40% Indians exposed to second hand smoke at home: WHO -Sushmi Dey
-The Times of India NEW DELHI: Even as the government is still deliberating on larger pictorial warnings on packs of tobacco products, 40% of Indian adults are exposed to second hand tobacco smoke at home. These are people who do not smoke themselves but are vulnerable to various diseases because someone smokes at home, showed a latest assessment by the World Health Organization, highlighting risks of second hand smoking and the need...
More »Soon, cancer medicines, stents to be cheaper -Sushmi Dey
-The Times of India NEW DELHI: Cancer medicines and stents may soon be available at a substantially lower price. The health ministry is working on a model to procure such drugs in bulk at a negotiated price and supply them to hospitals and consumers through its own retail system like 'Jan Aushadhi' stores. . The idea is to bring down prices of expensive cancer drugs and stents while not putting pressure on...
More »